Point72 Asset Management, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- CTMX
- Shares outstanding
- 162,743,000 shares
- Disclosed Ownership
- 4,068,575 shares
- Ownership
- 2.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 16:08:10 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 2.5% | 4,068,575 | 0 | 4,068,575 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 2.5% | 4,068,575 | 0 | 4,068,575 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 2.5% | 4,068,575 | 0 | 4,068,575 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |